Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „substrate“
Suchtreffer
Begriffe & Kennungen
Baraclude · 4.5 · Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450 (CYP450) enzymes (see section 5.2)
Eintrag öffnenBesponsa · 4.5 · 8 to alter the exposure of substrates of CYP enzymes, and N-acetyl-gamma-calicheamicin dimethylhydrazide is un
Eintrag öffnenBesremi · 4.5 · Therefore, care should be taken when ropeginterferon alfa-2b is co- substrates notably those having a narrow t
Eintrag öffnenBesremi · 4.5 · substrate).
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on CYP2D6 substrates In healthy volunteers, the inhibitory potency of mirabegron towards
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on CYP2D6 substrates In healthy volunteers, the inhibitory potency of mirabegron towards
Eintrag öffnenBetmiga · 4.5 · Mirabegron is transported and metabolised through multiple pathways. Mirabegron is a substrate for cytochrome
Eintrag öffnenBetmiga · 4.5 · Mirabegron is transported and metabolised through multiple pathways. Mirabegron is a substrate for cytochrome
Eintrag öffnenBeyonttra · 4.5 · Acoramidis is a substrate for BCRP. Based on an in vitro study, a clinically relevant interaction with BCRP in
Eintrag öffnenBiktarvy · 4.5 · Bictegravir is a substrate of CYP3A and UGT1A1. Co-administration of bictegravir and medicinal products that p
Eintrag öffnenBiktarvy · 4.5 · Bictegravir is both a P-gp and a BCRP substrate. The clinical relevance of this feature is not established. Th
Eintrag öffnenBraftovi · 4.5 · CYP substrates Encorafenib is a strong inducer of CYP3A4. Concomitant use with agents that are substrates of C
Eintrag öffnenBraftovi · 4.5 · Transporter substrates In vivo, encorafenib is an inhibitor of OATP1B1, OATP1B3 and/or BCRP. Coadministration
Eintrag öffnenBrilique · 4.5 · 7 There was no effect of ticagrelor on cyclosporine blood levels. Effect of ticagrelor on other P-gp substrate
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol
Eintrag öffnenBrilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol
Eintrag öffnenBrilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol
Eintrag öffnen